Silica nanoparticles (SiO2 NPs) have been
widely applied
in diverse areas, thus causing the extensive release through multiple
routes. Their toxicological effects, especially for the disturbance
in hematological homeostasis, have raised public concern. Considering
the detrimental role of excessive platelets in many cardiovascular
diseases, the regulation of platelet formation offers a unique aspect
for studying the blood compatibility of nanomaterials. In this study,
the effects of SiO2 NPs with four sizes (80, 120, 200,
and 400 nm) were investigated on the maturation and differentiation
of the megakaryocytes into platelets. The results showed that SiO2 NPs promoted megakaryocyte development as manifested by the
occurrence of irregular cell morphology, enlargement of cell size,
increases in DNA content and DNA ploidy, and formation of spore-like
protrusions. The expression of megakaryocyte-specific antigen (CD41a)
was up-regulated, due to SiO2 NP treatments. The correlation
analysis of SiO2 NP size with the above test bioindicators
showed that the smaller the SiO2 NPs were, the stronger
effects they induced. Moreover, exposure to SiO2 NPs induced
the up-regulation of both GATA-1 and FLI-1, while the transcriptional expressions of aNF-E2 and fNF-E2 remained unchanged. The significant
positive correlation of GATA-1 and FLI-1 with megakaryocytic maturation and differentiation suggested their
crucial roles in the SiO2 NP-promoted effect. The finding
herein provided new insight into the potential health risk of SiO2 NPs by perturbing the platelet-involved hematological homeostasis.